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Jan P. Dutz1
The lichenoid tissue reaction is a histopathologic
pattern of skin inflammation noted in a diverse group
of clinical diseases. Although few of these diseases are
reflected in animal models, select murine models of
skin inflammation recapitulate salient characteristics
of the lichenoid tissue reaction pattern. Animal
models of predominantly T-cell-mediated skin inflam-
mation induced by the adoptive transfer of T-cell
clones, by the generation of autoreactive T-cell
receptor transgenic T cells, and by genetic manipula-
tion of the epidermis are reviewed. Their relevance
for a better understanding of the lichenoid tissue
reaction is discussed.
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INTRODUCTION: DEFINITION AND SCOPE OF THE
PROBLEM
The lichenoid tissue reaction (LTR) or interface dermatitis is a
specific pattern of skin injury that is common to multiple
disease processes. Unifying concepts behind this injury
reaction pattern were identified by careful histologic analysis
and include (1) epidermal cell damage with prominent
keratinocyte cell death most pronounced at the basal-cell
layer; (2) the subsequent formation of Civatte bodies in the
epidermis and colloid bodies in the dermis; and (3) a
prominent mixed mononuclear cell infiltrate at the dermoe-
pidermal junction that ‘‘obscures the junction’’ (Ragaz and
Ackerman, 1981; Sontheimer and Gilliam, 1981; Weedon,
1982). The nomenclature and nosology of the LTR-interface
dermatitis pattern is well described in an accompanying
article by Sontheimer and Gilliam (1981). The diseases that
share this histologic reaction pattern have been classified into
those with a prominent cellular infiltrate at the dermoepi-
dermal junction (termed ‘‘cell rich’’) and those with a sparse
cellular infiltrate, despite evidence of basilar keratinocyte
damage (termed ‘cell poor’). Diseases exemplifying the cell-
rich LTR include lichen planus, fixed drug eruption (FDE),
and toxic epidermal necrolysis (TEN). Diseases exemplifying
cell-poor LTR include cutaneous lupus erythematosus,
cutaneous dermatomyositis, and the cutaneous manifesta-
tions of graft-versus-host disease (GVHD). Features of cell-
poor LTR are also shared by lichen sclerosus, morphea, and
vitiligo whereas features of cell-rich LTR (apoptosis and
mononuclear cell infiltrate) are also seen in alopecia areata.
The multiplicity of clinical manifestations of this reaction
pattern is thus broad and presents a challenge to the biologist
tasked to explain mechanistic differences and similarities
between these conditions. Nevertheless, a study of the
commonalities between these conditions promises to reveal
important principles of skin biology.
THE EVOLUTION OF THE LICHENOID TISSUE
REACTION: PRINCIPLES FOR THE STUDY OF ANIMAL
MODELS
Careful analysis of biopsy specimens of lichen planus to
assess the histologic correlates of evolution, maturation, and
regression demonstrated that epidermal dendritic cells or
Langerhans cells increase in numbers early in disease,
followed by the appearance of lymphocytes at the epider-
modermal junction, keratinocyte death, and eventual hyper-
plasia (Ragaz and Ackerman, 1981). The concept that an
autoimmune attack by T cells upon the epidermis represents
the primary pathologic event in the LTR (reviewed by
Shiohara and Mizukawa, 2005) eventually followed these
observations. Study of established clinical disease in humans
obscures the potential initiating events in the disease process.
One way of circumventing this limitation in humans, as
pioneered by Shiohara, is the study of FDEs. These eruptions
are elicited by specific drug exposure, demonstrate a typical
pattern of lichenoid inflammation, and moreover, manifest a
‘‘recall response’’ where previously affected but clinically
normal skin develops recurrent lesions after drug challenge
(Shiohara and Mizukawa, 2007).
The predictable recurrence of lesions following drug
challenge has allowed the histologic analysis of preclinical
lesions within hours of drug challenge. Even before rechal-
lenge, a slight increase in lymphocyte numbers is detected at
the dermoepidermal interface when compared to previously
uninvolved skin. Immunohistochemical analysis has
identified a predominance of CD8þ T cells within this
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prechallenge epidermis whereas CD4þ T cells predominate
in the perivascular and dermal compartments. The epidermal
cells express CD45RA and CD11b, consistent with an
effector memory phenotype and the skin homing markers
CLA and aEb7 (Mizukawa et al., 2002). These cells also
express the early activation marker CD69 but not CD25,
suggesting the possibility of a low level of ongoing stimula-
tion, possibly from self-antigen. Within 3 hours of drug
administration, the CD8þ T cells migrate from intraepider-
mal locations to the basal epidermis, and produce the
inflammatory cytokine interferon-g. Simultaneously, CD4þ
T cells begin to accumulate at the dermoepidermal junction.
Analysis of active FDE lesions has revealed that the activation
of the intraepidermal CD8þ T cells is associated with the
apoptotic death of keratinocytes manifested by keratinocyte-
specific caspase-3 expression and terminal deoxynucleotidyl
transferase-mediated deoxyuridine triphosphate nick-end
labeling staining (Choi et al., 2006). The keratinocytes are
induced to express Fas and the mononuclear cell infiltrate to
express FasL providing a possible upstream mechanism for
the induction of apoptosis.
TEN is a more severe form of LTR with the induction of
significant epidermal damage. Roujeau and colleagues have
characterized this form of drug-induced skin damage (Nassif
et al., 2004). Analysis of T cells within the blister fluid
obtained from lesions demonstrates a preponderance of
CD8þ T cells that demonstrate drug-specific perforin and
granzyme-mediated cytotoxicity toward keratinocytes.
A comparison of these two forms of drug-mediated LTR
reveals that different cytotoxic mechanisms may be involved
as the CD8þ T cells in FDE rarely express granzyme. Further,
CD4þCD25þ IL-10-secreting regulatory T cells are promi-
nent in FDE lesions, possibly limiting epidermal damage
(Teraki and Shiohara, 2003) but are not detected in TEN.
Keratinocytes likely participate in the onset of LTRs and
the recruitment of T cells into the epidermis as induction of
basal keratinocyte expression of intracellular adhesion
molecule 1, a molecule that promotes T-cell adhesion, and
migration has been noted in lichen planus and cutaneous
lupus erythematosus (Bennion et al., 1995). Thus a careful
analysis of human LTR tissues has revealed that common
events in the pathogenesis of lesions include the activation of
skin dendritic cells, keratinocytes, the recruitment and
activation of CD8þ and CD4þ T cells, followed by cytotoxic
keratinocyte damage and possibly regulatory T-cell-mediated
resolution of lesions (Figure 1). Further analysis of the cellular
phenotypes accompanying these reactions and the cytokines-
and chemokines-mediating cell behavior in these reactions is
the subject of current human-based research summarized by
(Meller et al., in press) and (Wenzel and Tu¨ting, 2008) at the
‘‘Lichenoid Tissue Reaction’’ session of the 2007 Montagna
Symposium. Credible animal models must recapitulate and
build upon these findings. Select murine models that fulfill
these criteria are presented herein.
LTR INDUCTION BY AUTOREACTIVE T CELL CLONES
To study the potential role of CD4þ T cells in the genesis of
the LTR, Shiohara et al. (1987) generated autoreactive T-cell
clones from the skin-draining lymph nodes of mice
immunized with the purified protein derivative of mycobac-
terium tuberculosis. These clones responded to self class II
major histocompatibility complex molecules by producing
both lymphotoxin and interferon-g. Injection of these clones
into the footpads of mice produced a delayed-type hyper-
sensitivity reaction with infiltration of the T cells into the
epidermis, consequent keratinocyte class II major histocom-
patibility complex expression, and an LTR with Civatte body
formation and satellite cell necrosis. This demonstrated that
T-cell reactivity for autologous class II major histocompat-
ibility complex was sufficient to induce an LTR. It is assumed
that the generation of autoreactive T-cell clones was a by-
product of the immune response to purified protein derivative
in the donor mice and the autoreactive nature of these cells,
as well as the lack of bacterial adjuvant in the transfer system,
likely determines the focal nature of the LTR response. Study
of heterologous human lymphocytes injected into human
skin xenografted upon immunodeficient mice revealed that
migration of activated interferon-g-producing CD8þ T cells
into the skin mediated apoptotic damage of keratinocytes
(Christofidou-Solomidou et al., 1997). Again, induction of
epidermal intracellular adhesion molecule 1 expression was
noted, recapitulating the observations in patients. This work
demonstrated clearly that alloreactive human CD8þ T cells
may also induce an LTR.
MODELS OF LTR WITH DEFINED ANTIGENS
The generation of T-cell receptor transgenic mice has
allowed the production of animals that may provide a ready
source of naive T cells specific for defined antigens. This tool,
when combined with animals expressing defined antigens in
the skin by means of skin-specific genetic promoters, has
allowed the detailed study of the role of self-reactive T cells
in the generation of LTR in mice. Expression of the model
KC
T cell
DC
Cell-mediated
immune damage
Trigger (virus, drug, cell damage)
TLR/inflammasome activation
T-cell activation
Chemokine/cytokine release Antigen processing
T-cell instruction
Treg cell
Migration
Civatte bodies
Colloid bodies
Langerhans cells
Dermal DC
CD4 T cells
CD8 T cells
Antigen release
↓
Figure 1. Essential components of the lichenoid tissue reaction. Common
events in the lichenoid tissue reaction include activation of skin dendritic cells
and keratinocytes, recruitment and activation of CD4 and CD8 T cells,
followed by cytotoxic damage to keratinocytes with release of keratinocyte
antigens in the form of Civatte bodies or colloid bodies.
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antigen chicken ovalbumin (OVA) in a membrane-bound
form by keratinocytes in the epidermis and hair follicles has
been achieved using the keratin 5 promoter (K5 mOVA mice;
Azukizawa et al., 2003). When these mice receive an
infusion of OVA-specific CD8þ T cells, the T cells home to
the epidermis and follicular epithelium as well as the dermis.
This is associated with the appearance of deoxynucleotidyl
transferase-mediated deoxyuridine triphosphate nick-end
labeling-positive apoptotic keratinocytes but little clinical
disease. When host T cells are depleted, either by sublethal
irradiation or by the athymic (nude) genetic phenotype, a
spontaneous clinical disease with liquefaction of basal cells,
blister formation, and inflammatory degeneration of hair
follicles reminiscent of TEN develops. Bone marrow trans-
plant experiments demonstrated that bone-marrow-derived
antigen-presenting cells (presumably dendritic cells) with the
appropriate major histocompatibility complex were required
to activate the CD8þ T cells. The requirement of T-cell
depletion for full disease expression suggested the presence
of a population of regulatory T cells competent in the
downregulation of the inflammatory response.
To further identify the regulatory T cells limiting CD8þ
T-cell-mediated damage to the epidermis, Azukizawa et al.
(2005) generated mice that expressed both the OVA antigen
in the skin and OVA-specific CD8þ T cells. These mice were
tolerant of the self-antigen expressed in the skin. However,
when the investigators depleted the CD4þ T cells from these
mice, or in the absence of a thymus (where endogenous
regulatory T cells generated), severe skin inflammation
reminiscent of TEN developed. The transfer of a
CD4þCD25þ subset of regulatory T cells prevented the
expression of disease when these cells were cotransferred
with dendritic cells (Azukizawa et al., 2005). These experi-
ments demonstrate that a severe form of LTR (TEN-like
disease), mediated by CD8þ T cells, can be controlled by
CD4þCD25þ regulatory T cells and that dendritic cells are
required for the activation of these regulatory cells.
The adoptive transfer experiments of Shiohara et al. (1987)
demonstrated that activated clones of self-reactive CD4þ
T cells are capable of inducing an LTR. Naive self-reactive
CD4þ T cells may likewise induce disease. The adoptive
transfer of OVA-specific CD4þ T cells into mice expressing
soluble OVA and otherwise deficient in T cells because of an
absence of RAG resulted in epidermal cell apoptosis and
marked dermal/epidermal T-cell infiltration characteristic of
acute GVHD (Knoechel et al., 2005). These mice recover from
this inflammatory skin disease within 2–3 weeks. FoxP3 is a
transcription factor well associated with a regulatory phenotype
in CD4þ T cells. The recovery from disease in these mice is
associated with the generation of OVA-specific T-cell receptor
bearing CD4þCD25þ markers and expressing the FoxP3
transcription factor. Thus, either self-reactive CD8þ T cells or
CD4þ T cells may induce LTRs and both forms of disease are
susceptible to modulation by regulatory T cells. Regulatory T
cells are not the only modulators of the LTR as autoreactive T-
cell deletion (Waithman et al., 2007) and anergy induction
(Mayerova et al., 2006) within the skin-draining lymph nodes
have also been noted coincident with disease resolution.
With either CD4þ or CD8þ self-reactive T cells, a TH1
pattern of inflammation with T-cell-derived interferon-g
production has been described. IL-17 is a previously
unidentified proinflammatory cytokine that participates in
T-cell-mediated skin inflammation such as contact hypersen-
sitivity (Nakae et al., 2002). The tissue inflammation in CD4þ
T-cell-mediated acute GVHD to soluble OVA is IL-17
dependent as an antibody to IL-17 was able to improve
inflammatory skin scores and alopecia in this model (Lohr
et al., 2006). The importance of IL-17 in the pathogenesis of
psoriasis has been recently underscored (Zaba et al., 2007).
However, the relevance of this concept to the LTR remains to
be more fully explored.
MODELS OF SPONTANEOUS LTR: THE ROLES OF
DENDRITIC CELLS AND KERATINOCYTES
The analysis of immune responses to artificial self-antigens as
described above has revealed that bone-marrow-derived
antigen-presenting cells are required for the activation of
the T cells to skin-derived antigens (Azukizawa et al., 2003).
Overexpression of CD40 ligand, a costimulatory molecule for
dendritic cells, within the epidermis is sufficient to induce
systemic autoimmunity with autoantibodies and features of
graft-versus-host-like LTR (Mehling et al., 2001). This disease
is associated with recruitment of dendritic cells within the
skin-draining lymph nodes and with the activation of
pathogenic CD8þ T cells that infiltrate the skin and are able
to induce disease when transferred into healthy hosts. This
observation demonstrates that keratinocyte-mediated activa-
tion of skin dendritic cells can initiate both an LTR and
systemic autoimmunity. Both epidermal Langerhans cells and
dermal dendritic cells have been shown to acquire keratino-
cyte-derived antigens and prime CD8þ T cells to these
antigens within the skin-draining lymph nodes (Waithman
et al., 2007). Dermal dendritic cells have been recently
shown to promote cellular immune reactions to epidermal
antigen independently of epidermal Langerhans cells (Bursch
et al., 2007; Ginhoux et al., 2007; Poulin et al., 2007). The
relative roles of dermal versus epidermal dendritic cells in
inducing LTRs remain to be explored.
Models of altered type 1 interferon signaling
Human observational data have strongly implicated type 1
interferon signaling, type 1 interferon inducible genes, and
the activation of cutaneous plasmacytoid dendritic cells in
lichen planus, the prototypic LTR (Wenzel et al., 2006,
2008). The role of type 1 interferons and plasmacytoid
dendritic cells remains less explored in animal models of
LTR. Mice deficient in the interferon regulatory factor-2
exhibit enhanced type 1 interferon responses leading to a
CD8þ T-cell dependent inflammatory disease (Hida et al.,
2000). These mice showed erythema, hair loss, and ulcera-
tion that were manifested histopathologically as keratinocyte
activation with intracellular adhesion molecule 1 expression
and basilar CD4þ and CD8þ T-cell infiltration. Despite an
absence of detectable increases in interferon-a or
-b, interferon-related genes such as 2050-oligoadenylate
synthetase were increased within the skin and genetic
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blockade of interferon signaling abolished the disease.
Downstream interferon-g production by the activated mem-
ory CD8þ T cells (Arakura et al., 2007) was critical for
disease induction in this model.
KC activation and LTR
Keratinocytes are fully competent immune players (Kupper,
1990) and cross talk between keratinocytes and lymphocytes
may modulate inflammatory skin disease (Rebholz et al.,
2007). Keratinocyte-derived IL-1-b and tumor-necrosis factor-
a are well-known inducers of dendritic cell activation and
migration. Overexpression of tumor-necrosis factor-a in the
skin induces a GVHD-like phenotype (Cheng et al., 1992).
Overexpression of IL-1 within the skin results not only in
epidermal hyperplasia, but in a monocyte-rich inflammatory
infiltrate within the dermis (Groves et al., 1995). Over-
expression of interferon-g within the skin results in increased
epidermal cell death, dermal LTR-like inflammation, hair
loss, hypopigmentation, and lupus-like systemic autoimmu-
nity (Carroll et al., 1997; Seery et al., 1997). Which stimuli
induce cytokine production within the epidermis? TLRs are
pathogen recognition molecules expressed by keratinocytes
(Kollisch et al., 2005; Lebre et al., 2007) as well as
Langerhans cells (Renn et al., 2006). Stimulation of epidermal
TLR by pathogens or endogenous ligands released through
physical or drug-mediated skin damage may participate in
the initiation of keratinocyte and dendritic cells activation
preceding the development of LTRs (Sugita et al., 2007).
Local inflammation may also be required to permit the
recruitment of previously activated T cells into the skin. Study
of acute GVHD in murine bone marrow chimeras has shown
that local skin inflammation subsequent to TLR activation (for
example by the topical application of the TLR7 agonist
imiquimod) is required for the local induction of cutaneous
GVHD (Chakraverty et al., 2006). Interestingly, dendritic
cells within the skin-draining lymph node maintain a normal
phenotype in the absence of TLR signaling and in germ-free
mice, suggesting that other stimuli or endogenous genetic
programs mediate constitutive dendritic cell activation
(Wilson et al., 2008). A candidate for such a stimulus is the
inflammasome, a multimeric molecular complex that con-
trols the activation of caspase-1 (Ogura et al., 2006) and that
is present in keratinocytes (Watanabe et al., 2007). In favor of
this hypothesis, uric acid, a potential endogenous activator of
the inflammasome enhances skin-draining lymph node
activation and skin-directed T-cell predominant immune
responses (Liu et al., 2007).
Whereas plasmacytoid dendritic cells are known to
produce large amounts of type 1 interferons, other sources
of these cytokines may be important in LTRs. Direct type 1
interferon production by keratinocytes has been noted in
human LTRs such as lichen planus (Wenzel et al., 2008), and
cutaneous lupus erythematosus (Reefman et al., 2008).
Keratinocytes can be induced to produce type 1 interferons
by the TLR3 ligand double-stranded viral RNA with
consequent conditioning of dendritic cells to promote TH1
T-cell activation (Liu et al., 2007). The regulation of
keratinocyte production of interferons and other inflammatory
mediators and subsequent effects in the induction and
promotion of the LTR using murine models with defined
self-antigens or models of GVHD remains areas worthy of
investigation.
MODELING THERAPY IN MICE
As dendritic cells likely orchestrate the initiation of T-cell-
mediated immune responses such as LTR, a better under-
standing of the effects of current therapies for the LTR upon
these cells is required. The animal models described may
provide convenient systems for this reexamination. Antima-
larial drugs such as quinacrine are effective against cutaneous
lupus erythematosus, dermatomyositis, and GVHD. One
major mode of action of these drugs is now felt to be the
inhibition of endosomal TLR (TLR3, 7, 8, and 9) signaling
(reviewed by Kalia and Dutz, 2007). Quinacrine has been
recently shown to inhibit Langerhans cell migration in
response to haptens through the downregulation of NF-kB
and consequent tumor-necrosis factor-a, IL-1, and CCL21
release in the skin (Gorbachev et al., 2007). Calcineurin
inhibition is effective in the treatment of severe lichen planus.
Likewise, established autoimmunity induced by overexpres-
sion of CD40L within the skin can be controlled by FK506
(Loser et al., 2006). Although this is was felt to be mediated
primarily through the drug’s effects upon T cells, calcineurin
inhibitors have been recently shown to have profound effects
upon the activation state of dendritic cells in vivo (Haider
et al., 2008). A better understanding of the manipulation of
dendritic cells may enable the generation of regulatory T cells
specifically tailored to inhibit LTR. Ex vivo generated
regulatory T cells are able to control established autoimmu-
nity in the CD40L transgenic mice (Loser et al., 2005). Protein
Table 1. Murine models used in the generation and
study of therapy of lichenoid tissue reactions
T cells as mediators
K Adoptive transfer of autoreactive CD4 T cells (Shiohara et al., 1987)
K Adoptive transfer of alloreactive CD8 T cells (Christofidou-
Solomidou et al., 1997)
Manipulation of keratinocyte antigen expression
K Keratin-promoter-driven antigen expression (Azukizawa et al.,
2003)
K Ubiquitous soluble antigen expression (Knoechel et al., 2005)
Immune activation within the epidermis
K CD40 ligand expression by keratinocytes (Mehling et al., 2001)
K Epidermal overexpression of TNF-a (Cheng et al., 1992)
K Epidermal overexpression of IL-1 (Groves et al., 1995)
K Epidermal overexpression of IFN-g (Carroll et al., 1997)
K Manipulation of the skin in models of graft-versus-host disease
(Chakraverty et al., 2006), topical TLR7 agonist administration
Therapy of lichenoid tissue reactions
K Calcineurin inhibition (Loser et al., 2006)
K Regulatory T-cell therapy (Loser et al., 2005)
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and peptide vaccination through UV-irradiated skin may be
used to generate antigen-specific regulatory T cells capable of
inhibiting the priming and reactivation of CD8þ T cells
directly in vivo (Ghoreishi and Dutz, 2006). More efficient
and cost-effective strategies to induce antigen-specific
regulatory T cells need to be developed and tested.
CONCLUDING COMMENTS
Animal models of disease are almost always imperfect. This is
also true for the group of diseases that give rise to LTRs. For
example, no representative animal models exist for lichen
planus, the prototypical LTR, or for dermatomyositis. Animal
models for the cutaneous forms of lupus erythematosus are
imperfect (Furukawa, 2003). By reducing the LTR to the
essential components and surveying the literature, the author
has compiled and described murine models that shed light
upon crucial elements of the LTR (summarized in Table 1).
We hope that readers/investigators will be stimulated to use
these models as a point of departure to further clarify the
mechanisms that initiate and perpetuate diseases resulting
from T-cell assault upon the epidermis.
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